Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Barrett's esophagus: genetic and cell changes. Annals of the New York Academy of Sciences Souza, R. F., Freschi, G., Taddei, A., Ringressi, M. N., Bechi, P., Castiglione, F., Rossi Degl'Innocenti, D., Triadafilopoulos, G., Wang, J. S., Chang, A. C., Barr, H., Bajpai, M., Das, K. M., Schneider, P. M., Krishnadath, K. K., Malhotra, U., Lynch, J. P. 2011; 1232: 18-35

Abstract

The following includes commentaries on how genetic code of Barrett's esophagus (BE) patients, the mechanisms for GERD-induced esophageal expression of caudal homeobox, and the development of Barrett's metaplasia are increasingly better known, including the role of stromal genes in oncogenesis. Additional lessons have been learned in vitro models in nonneoplastic cell lines, yet there are limitations to what can be expected from BE-derived cell lines. Other topics discussed include clonal diversity in Barrett's esophagus; the application of peptide arrays to clinical samples of metaplastic mucosa; proliferation and apoptosis of Barrett's cell lines; tissue biomarkers for neoplasia; and transcription factors associated with BE.

View details for DOI 10.1111/j.1749-6632.2011.06043.x

View details for PubMedID 21950805